1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Patel, P. Clarke, C.J. Barraclough, D.L. Rudland, P.S. Barraclough, R. Lian, L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 425 929 943 10.1016/j.jmb.2012.12.009 23274113 Metastasis-promoting anterior gradient 2 protein has a dimeric thioredoxin fold structure and a role in cell adhesion. 2013 10.2210/pdb2lnt/pdb pdb_00002lnt 16130.548 Anterior gradient protein 2 homolog UNP residues 41-175 E60A 1 man polymer AG-2, hAG-2, HPC8, Secreted cement gland protein XAG-2 homolog no no IDPFTPQTLSRGWGDQLIWTQTYEAALYKSKTSNKPLMIIHHLDECPHSQALKKVFAENKEIQKLAEQFVLLNLVYETTD KHLSPDGQYVPRIMFVDPSLTVRADITGRYSNRLYAYEPADTALLLDNMKKALKLLKTEL IDPFTPQTLSRGWGDQLIWTQTYEAALYKSKTSNKPLMIIHHLDECPHSQALKKVFAENKEIQKLAEQFVLLNLVYETTD KHLSPDGQYVPRIMFVDPSLTVRADITGRYSNRLYAYEPADTALLLDNMKKALKLLKTEL A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample AGR2, AG2, UNQ515/PRO1030 9606 Homo sapiens 562 Escherichia coli pET-151D database_2 pdbx_database_status pdbx_nmr_software pdbx_nmr_spectrometer struct_ref_seq_dif repository Initial release Database references Database references Data collection Database references Other 1 0 2013-01-09 1 1 2013-01-30 1 2 2013-03-06 1 3 2023-06-14 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details BMRB Y RCSB 2012-01-04 REL REL REL REL structures with the lowest energy 200 10 2D 1H-15N HSQC 2D 1H-13C HSQC 3D HNCA 3D HN(CO)CA 3D HNCACB 3D CBCA(CO)NH 3D HNCO 3D 1H-13C NOESY 3D 1H-15N NOESY 3D HN(CA)CO IPAP 3D HBHA(CO)NH 3D HBHANH 0.3 mM [U-13C; U-15N] 0.3 mM [U-15N] 10 mg/mL 0.1 6.5 ambient 298 K simulated annealing, refinement 1 lowest energy 0.3 mM [U-13C; U-15N] AGR2 E60A, 90% H2O/10% D2O 90% H2O/10% D2O 0.3 mM [U-15N] AGR2 E60A, 10 mg Pf1 phage, 90% H2O/10% D2O 90% H2O/10% D2O Brunger, Adams, Clore, Gros, Nilges and Read structure solution CNSSOLVE CCPN peak picking Analysis CCPN chemical shift assignment Analysis Schwieters, Kuszewski, Tjandra and Clore refinement X-PLOR NIH Bruker Biospin collection TopSpin Bruker Biospin processing TopSpin Brunger, Adams, Clore, Gros, Nilges and Read refinement CNSSOLVE 600 Bruker AVANCE Bruker Avance 800 Bruker AVANCE Bruker Avance ILE 36 n 1 ILE 36 A ASP 37 n 2 ASP 37 A PRO 38 n 3 PRO 38 A PHE 39 n 4 PHE 39 A THR 40 n 5 THR 40 A PRO 41 n 6 PRO 41 A GLN 42 n 7 GLN 42 A THR 43 n 8 THR 43 A LEU 44 n 9 LEU 44 A SER 45 n 10 SER 45 A ARG 46 n 11 ARG 46 A GLY 47 n 12 GLY 47 A TRP 48 n 13 TRP 48 A GLY 49 n 14 GLY 49 A ASP 50 n 15 ASP 50 A GLN 51 n 16 GLN 51 A LEU 52 n 17 LEU 52 A ILE 53 n 18 ILE 53 A TRP 54 n 19 TRP 54 A THR 55 n 20 THR 55 A GLN 56 n 21 GLN 56 A THR 57 n 22 THR 57 A TYR 58 n 23 TYR 58 A GLU 59 n 24 GLU 59 A ALA 60 n 25 ALA 60 A ALA 61 n 26 ALA 61 A LEU 62 n 27 LEU 62 A TYR 63 n 28 TYR 63 A LYS 64 n 29 LYS 64 A SER 65 n 30 SER 65 A LYS 66 n 31 LYS 66 A THR 67 n 32 THR 67 A SER 68 n 33 SER 68 A ASN 69 n 34 ASN 69 A LYS 70 n 35 LYS 70 A PRO 71 n 36 PRO 71 A LEU 72 n 37 LEU 72 A MET 73 n 38 MET 73 A ILE 74 n 39 ILE 74 A ILE 75 n 40 ILE 75 A HIS 76 n 41 HIS 76 A HIS 77 n 42 HIS 77 A LEU 78 n 43 LEU 78 A ASP 79 n 44 ASP 79 A GLU 80 n 45 GLU 80 A CYS 81 n 46 CYS 81 A PRO 82 n 47 PRO 82 A HIS 83 n 48 HIS 83 A SER 84 n 49 SER 84 A GLN 85 n 50 GLN 85 A ALA 86 n 51 ALA 86 A LEU 87 n 52 LEU 87 A LYS 88 n 53 LYS 88 A LYS 89 n 54 LYS 89 A VAL 90 n 55 VAL 90 A PHE 91 n 56 PHE 91 A ALA 92 n 57 ALA 92 A GLU 93 n 58 GLU 93 A ASN 94 n 59 ASN 94 A LYS 95 n 60 LYS 95 A GLU 96 n 61 GLU 96 A ILE 97 n 62 ILE 97 A GLN 98 n 63 GLN 98 A LYS 99 n 64 LYS 99 A LEU 100 n 65 LEU 100 A ALA 101 n 66 ALA 101 A GLU 102 n 67 GLU 102 A GLN 103 n 68 GLN 103 A PHE 104 n 69 PHE 104 A VAL 105 n 70 VAL 105 A LEU 106 n 71 LEU 106 A LEU 107 n 72 LEU 107 A ASN 108 n 73 ASN 108 A LEU 109 n 74 LEU 109 A VAL 110 n 75 VAL 110 A TYR 111 n 76 TYR 111 A GLU 112 n 77 GLU 112 A THR 113 n 78 THR 113 A THR 114 n 79 THR 114 A ASP 115 n 80 ASP 115 A LYS 116 n 81 LYS 116 A HIS 117 n 82 HIS 117 A LEU 118 n 83 LEU 118 A SER 119 n 84 SER 119 A PRO 120 n 85 PRO 120 A ASP 121 n 86 ASP 121 A GLY 122 n 87 GLY 122 A GLN 123 n 88 GLN 123 A TYR 124 n 89 TYR 124 A VAL 125 n 90 VAL 125 A PRO 126 n 91 PRO 126 A ARG 127 n 92 ARG 127 A ILE 128 n 93 ILE 128 A MET 129 n 94 MET 129 A PHE 130 n 95 PHE 130 A VAL 131 n 96 VAL 131 A ASP 132 n 97 ASP 132 A PRO 133 n 98 PRO 133 A SER 134 n 99 SER 134 A LEU 135 n 100 LEU 135 A THR 136 n 101 THR 136 A VAL 137 n 102 VAL 137 A ARG 138 n 103 ARG 138 A ALA 139 n 104 ALA 139 A ASP 140 n 105 ASP 140 A ILE 141 n 106 ILE 141 A THR 142 n 107 THR 142 A GLY 143 n 108 GLY 143 A ARG 144 n 109 ARG 144 A TYR 145 n 110 TYR 145 A SER 146 n 111 SER 146 A ASN 147 n 112 ASN 147 A ARG 148 n 113 ARG 148 A LEU 149 n 114 LEU 149 A TYR 150 n 115 TYR 150 A ALA 151 n 116 ALA 151 A TYR 152 n 117 TYR 152 A GLU 153 n 118 GLU 153 A PRO 154 n 119 PRO 154 A ALA 155 n 120 ALA 155 A ASP 156 n 121 ASP 156 A THR 157 n 122 THR 157 A ALA 158 n 123 ALA 158 A LEU 159 n 124 LEU 159 A LEU 160 n 125 LEU 160 A LEU 161 n 126 LEU 161 A ASP 162 n 127 ASP 162 A ASN 163 n 128 ASN 163 A MET 164 n 129 MET 164 A LYS 165 n 130 LYS 165 A LYS 166 n 131 LYS 166 A ALA 167 n 132 ALA 167 A LEU 168 n 133 LEU 168 A LYS 169 n 134 LYS 169 A LEU 170 n 135 LEU 170 A LEU 171 n 136 LEU 171 A LYS 172 n 137 LYS 172 A THR 173 n 138 THR 173 A GLU 174 n 139 GLU 174 A LEU 175 n 140 LEU 175 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O VAL 105 A O VAL 70 A N MET 73 A N MET 38 A N LEU 72 A N LEU 37 A O VAL 131 A O VAL 96 A N HIS 77 A N HIS 42 A O LEU 109 A O LEU 74 5 A A HH21 OD2 ARG ASP 127 140 1.59 1 A LEU 44 69.91 -69.37 1 A ARG 46 64.40 91.56 1 A LEU 52 62.17 -94.84 1 A ILE 53 171.73 -34.46 1 A TRP 54 75.05 -48.38 1 A PRO 82 -37.00 122.86 1 A TYR 111 -179.95 119.26 1 A GLU 112 70.05 118.33 1 A THR 114 -119.17 78.48 1 A TYR 124 171.40 151.76 1 A PRO 126 -66.26 -146.78 1 A ARG 127 171.50 -43.09 1 A THR 136 -124.29 -166.21 1 A ASN 147 -158.21 55.74 1 A ARG 148 75.16 139.80 1 A PRO 154 -42.08 -17.13 1 A LEU 160 -39.49 -35.66 1 A LYS 169 58.08 -73.64 1 A THR 173 78.37 -55.06 2 A LEU 44 -147.94 -50.75 2 A SER 45 73.51 129.62 2 A THR 55 66.38 87.44 2 A ASN 69 54.28 82.08 2 A GLU 80 -85.48 33.67 2 A VAL 110 -90.03 47.53 2 A TYR 111 79.64 80.10 2 A GLU 112 -151.10 -76.26 2 A THR 114 -156.70 25.27 2 A PRO 126 -25.70 100.42 2 A ARG 127 -163.07 -162.74 2 A ALA 139 -113.52 67.51 2 A ARG 148 45.64 90.06 2 A TYR 152 -113.55 -129.59 2 A GLU 153 52.99 165.94 2 A THR 173 -45.90 152.92 3 A ASP 37 65.73 106.29 3 A GLN 42 68.52 174.26 3 A ASP 50 67.46 -172.94 3 A LEU 52 68.08 -86.76 3 A GLU 112 -157.54 -53.36 3 A VAL 125 -85.27 -75.64 3 A PRO 126 -47.77 93.17 3 A ARG 127 174.44 -177.06 3 A LEU 135 70.27 67.22 3 A ALA 139 -90.28 57.00 3 A TYR 152 -156.20 10.37 3 A ASP 156 -76.49 23.28 3 A LYS 172 -159.90 71.29 4 A SER 45 70.43 78.28 4 A TRP 54 -73.02 -71.94 4 A LYS 95 -43.42 -18.92 4 A PHE 104 -120.21 -166.08 4 A VAL 110 169.26 -48.61 4 A THR 113 72.95 73.46 4 A LEU 118 -91.71 32.20 4 A SER 119 52.47 87.90 4 A PRO 126 -38.08 108.80 4 A MET 129 -105.32 -169.60 4 A PRO 133 -48.70 -16.49 4 A ALA 139 -111.43 -79.15 4 A ARG 144 -87.95 -139.01 4 A GLU 153 110.14 164.28 4 A LYS 169 75.76 -68.64 4 A LYS 172 44.76 84.87 5 A ASP 37 73.80 112.50 5 A PHE 39 64.11 87.18 5 A TRP 48 68.86 -63.96 5 A GLN 51 58.24 83.05 5 A ASN 69 68.77 -9.34 5 A THR 113 -85.76 46.81 5 A ARG 127 -175.38 148.32 5 A PRO 133 -59.87 -8.26 5 A LEU 135 153.13 13.18 5 A ALA 139 69.53 -22.57 5 A ASP 140 68.13 102.01 5 A THR 142 -69.26 -174.38 5 A GLU 153 47.70 178.87 5 A PRO 154 -58.00 -0.53 5 A LYS 172 62.29 99.65 5 A GLU 174 -142.64 -59.19 6 A PHE 39 66.35 93.19 6 A PRO 41 -73.64 -153.94 6 A LEU 44 63.67 74.07 6 A ASP 50 71.99 158.50 6 A TYR 58 -78.46 -71.26 6 A ASN 69 119.49 62.21 6 A PRO 82 -38.76 123.10 6 A VAL 110 -171.98 -16.48 6 A TYR 111 -78.15 -73.15 6 A THR 113 175.72 -77.57 6 A THR 114 59.16 79.89 6 A VAL 125 -40.97 165.58 6 A PRO 126 -7.91 92.06 6 A ALA 139 -53.87 89.44 6 A ARG 144 80.25 177.27 6 A ASN 147 -59.34 3.35 6 A ARG 148 -169.98 24.52 6 A LEU 171 -160.61 86.28 6 A LYS 172 49.22 87.12 6 A THR 173 -99.54 -83.83 7 A ARG 46 -175.21 -17.54 7 A GLN 51 -89.77 -76.64 7 A ASN 69 63.51 75.18 7 A ASP 79 -90.57 -67.31 7 A GLU 112 -85.00 -157.25 7 A PRO 133 -56.31 -8.56 7 A ASP 140 -145.13 -51.20 7 A ASN 147 172.85 111.82 7 A ARG 148 88.25 89.14 7 A LYS 169 -149.45 44.47 8 A TRP 48 -77.77 -83.84 8 A TRP 54 -68.04 94.25 8 A THR 57 70.81 114.83 8 A PHE 104 -119.89 -165.75 8 A VAL 110 -126.84 -63.43 8 A VAL 125 -52.82 107.47 8 A ARG 127 64.73 -88.61 8 A THR 136 74.10 -177.22 8 A ASP 140 44.51 98.46 8 A ARG 148 -162.46 92.19 9 A ASP 37 66.59 102.24 9 A PRO 41 -57.45 -70.41 9 A GLN 42 -157.96 -51.43 9 A THR 43 58.75 82.84 9 A ARG 46 65.32 178.20 9 A THR 113 61.87 85.80 9 A SER 119 50.81 93.11 9 A PRO 126 -66.66 95.36 9 A ARG 127 -173.34 -176.05 9 A THR 136 -172.32 139.04 9 A THR 142 -178.81 -172.98 9 A ASN 147 -160.93 75.65 9 A ARG 148 39.85 74.38 9 A LYS 169 67.50 -168.71 10 A GLN 42 -178.39 -33.77 10 A LEU 44 64.98 74.16 10 A SER 45 -140.54 21.47 10 A TRP 48 68.69 149.51 10 A ASP 50 -166.52 95.53 10 A ILE 53 62.41 83.38 10 A GLU 80 -77.99 35.89 10 A SER 119 177.04 147.33 10 A ASP 121 -75.75 32.91 10 A VAL 125 -95.24 -119.42 10 A PRO 126 -11.57 83.37 10 A ASN 147 -57.24 -84.27 10 A PRO 154 -39.65 -19.31 lowest energy, model 1 Solution structure of E60A mutant AGR2 1 N N A THR 57 A THR 22 HELX_P A SER 68 A SER 33 1 1 12 A HIS 83 A HIS 48 HELX_P A ALA 92 A ALA 57 1 2 10 A ASN 94 A ASN 59 HELX_P A GLN 103 A GLN 68 1 3 10 A GLU 153 A GLU 118 HELX_P A ALA 155 A ALA 120 5 4 3 A ASP 156 A ASP 121 HELX_P A LYS 169 A LYS 134 1 5 14 CELL ADHESION Thioredoxin-fold, cancer, adhesion, metastasis, CELL ADHESION AGR2_HUMAN UNP 1 41 O95994 PQTLSRGWGDQLIWTQTYEEALYKSKTSNKPLMIIHHLDECPHSQALKKVFAENKEIQKLAEQFVLLNLVYETTDKHLSP DGQYVPRIMFVDPSLTVRADITGRYSNRLYAYEPADTALLLDNMKKALKLLKTEL 41 175 2LNT 41 175 O95994 A 1 6 140 1 expression tag ILE 36 2LNT A O95994 UNP 1 1 expression tag ASP 37 2LNT A O95994 UNP 2 1 expression tag PRO 38 2LNT A O95994 UNP 3 1 expression tag PHE 39 2LNT A O95994 UNP 4 1 expression tag THR 40 2LNT A O95994 UNP 5 1 GLU engineered mutation ALA 60 2LNT A O95994 UNP 60 25 3 2 parallel anti-parallel parallel A VAL 105 A VAL 70 A LEU 106 A LEU 71 A LEU 72 A LEU 37 A MET 73 A MET 38 A PHE 130 A PHE 95 A VAL 131 A VAL 96 A HIS 76 A HIS 41 A HIS 77 A HIS 42 A LEU 109 A LEU 74 A VAL 110 A VAL 75